Source: Contract Pharma

Calypso Biotech: AGC, Calypso Form Devt./Mfg. Deal

Enter agreement for process development and cGMP manufacture of CALY-002

Read full article »
Calypso Biotech's Competitors | Calypso Biotech's News | Calypso Biotech's Financials
Stay up-to-date with the latest news on Calypso Biotech
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alain Vicari's photo - Co-Founder & CEO of Calypso Biotech

Co-Founder & CEO

Alain Vicari

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Calypso Biotech